The Dependent Care Expansion of the ACA may have improved survival outcomes among cancer patients aged 19-25 years.

Although young breast cancer survivors who attempted to breastfeed were mostly satisfied with the experience, a majority reported not receiving specific information about breastfeeding after breast ...

In a randomized trial, transperineal and transrectal approaches to prostate biopsies offered similar rates of cancer detection, but transrectal biopsy was associated with a significantly higher ...

Phase 2 data support the feasibility of administering liso-cel in the community setting with outpatient monitoring in appropriate patients.

Data suggest that uptake of colorectal cancer screening increased after the USPSTF issued a recommendation that all average-risk individuals aged 45 to 49 years should undergo screening.

Some physicians have urged their colleagues and medical societies to move professional conferences out of states that criminalize abortion. When conferences are not moved, these physicians have called ...

Some physicians have urged their colleagues and medical societies to move professional conferences out of states that ...

The FDA has approved the Cologuard Plus test for colorectal cancer screening in adults age 45 years and older who are at average risk of colorectal cancer.

Female physicians remain underrepresented among residents entering high-compensation specialties, data suggest.

Gender-affirming hormone therapy may reduce the risk of prostate cancer in transgender women, but it may also increase the risk of biochemical recurrence and bone metastases in patients with prostate ...

A 2023 survey showed that 24% of Americans who used online pharmacies had been exposed to harmful or substandard medications.

Atezolizumab did not improve overall survival, progression-free survival, distant metastasis-free survival, or time to local failure.